Dr. Thomas Lycan
Claim this profileWake Forest University Health Sciences
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
5 reported clinical trials
11 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage IV
2Lung Cancer
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Thomas Lycan is currently running
Chemo/Immunotherapy Combo
for Head and Neck Cancer
The purpose of this research is to see what effects the treatment regimen chemotherapy (carboplatin and paclitaxel) plus immunotherapy (pembrolizumab), has on patients who have been diagnosed with head/neck squamous cell carcinoma and are unable to take the drug 5-fluorouracil
Recruiting1 award Phase 28 criteria
Quick Start Durvalumab
for Lung Cancer
This research study aims to determine what effects (good and bad) Durvalumab has on participants and their cancer with a "quick start" of Durvalumab within 14 days of finishing chemotherapy and radiation. The study will also determine the logistic barriers to the quick start of Durvalumab.
Recruiting1 award Phase 210 criteria
More about Thomas Lycan
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Thomas Lycan has experience with
- Carboplatin
- Paclitaxel
- Pembrolizumab
- Pemetrexed
- Durvalumab
- Nab Paclitaxel
Breakdown of trials Thomas Lycan has run
Non-Small Cell Lung Cancer
Lung Cancer
Skin Cancer
Cancer
Performance Status
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Lycan specialize in?
Thomas Lycan focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Thomas Lycan currently recruiting for clinical trials?
Yes, Thomas Lycan is currently recruiting for 5 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Thomas Lycan has studied deeply?
Yes, Thomas Lycan has studied treatments such as Carboplatin, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Thomas Lycan?
Apply for one of the trials that Thomas Lycan is conducting.
What is the office address of Thomas Lycan?
The office of Thomas Lycan is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.